Company / Financials
INTEGRATED BIOPHARMA INC Financials
FY2012-FY2018 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$43.7M
FY2018 · -6.9% YoY
Net Income
$679.0K
FY2018 · -71.1% YoY
Profit Margin
1.6%
FY2018 · net income / revenue
ROE
-
FY2018 · return on equity
Total Assets
$14.6M
FY2018
Total Debt
$9.3M
-1.78x debt/equity
Equity
-$5.2M
FY2018
ROA
4.7%
FY2018 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 0.15 (distress zone, below 1.23 threshold)
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$43.7M-6.9% YoYNet Income HistoryProfit after all expenses and taxes$679.0K-71.1% YoYGross Profit HistoryRevenue minus cost of goods sold$5.0M-25.2% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$38.7M-3.9% YoYOperating Income HistoryProfit from core business operations before interest and taxes$1.7M-46.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$3.3M-5.3% YoYInterest Expense HistoryCost of borrowing and debt obligations$926.0K+1.6% YoYIncome Tax HistoryTotal income tax expense$326.0K+166.5% YoYEPS (Basic) HistoryBasic earnings per share$0.11+120.0% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles$0.10+100.0% YoY